SCHEMBL14923165

SCHEMBL14923165

CCCc1nn(C)c(Cl)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.42
▸ RAB9A P51151 7/20 0.37
▸ NPC1 O15118 6/20 0.37
▸ LMNA P02545 5/20 0.37
▸ SMN1; SMN2 Q16637 5/20 0.37
▸ MAPT P10636 4/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ L3MBTL1 Q9Y468 4/20 0.34
▸ ATM Q13315 2/20 0.34
▸ MAPK8 P45983 1/20 0.34
▸ MAPK9 P45984 1/20 0.34
▸ MAPK10 P53779 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ POLB P06746 2/20 0.33
▸ NR1I2 O75469 1/20 0.33
▸ AHR P35869 1/20 0.33
▸ CDK4 P11802 1/20 0.31
▸ CCND1 P24385 1/20 0.31
▸ PDE5A O76074 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13295541 0.83 GAA (0.61) GAAL3MBTL1MAPK8MAPK9MAPK10
SCHEMBL10093022 0.78 GAA (0.41) GAARAB9ANPC1LMNASMN1; SMN2
SCHEMBL14572952 0.77 GAA (0.44) GAAL3MBTL1
SCHEMBL1852640 0.77 GAA (0.39) GAAL3MBTL1
SCHEMBL3605937 0.73 RAB9A (0.37) GAARAB9ANPC1LMNASMN1; SMN2
SCHEMBL9218943 0.72 RAB9A (0.45) RAB9ANPC1LMNASMN1; SMN2MAPT
SCHEMBL12844013 0.71 ALDH1A1 (0.40) GAARAB9ANPC1LMNASMN1; SMN2
SCHEMBL23384509 0.69 SMN1; SMN2 (0.48) GAARAB9ANPC1LMNASMN1; SMN2
SCHEMBL5274911 0.68 GABRB3 (0.36) RAB9ANPC1LMNAALDH1A1NR1I2
SCHEMBL14981439 0.68 PDE5A (0.38) GAARAB9ANPC1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256728-A1 COMPOUNDS WITH NEMATICIDAL ACTIVITY BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-09-11 — — US disclosed
EP-2589294-A1 Compounds with nematicidal activity Bayer CropScience AG (DE) 2013-05-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256728-A1 COMPOUNDS WITH NEMATICIDAL ACTIVITY ACHE, TUBA3C, NAAA GAA 1508/4885RAB9A 1739/4885NPC1 1627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback